{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:11:47Z","timestamp":1759191107710,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research and Technology","doi-asserted-by":"publisher","award":["7177"],"award-info":[{"award-number":["7177"]}],"id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.virusres.2022.198852","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T18:03:39Z","timestamp":1657562619000},"page":"198852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5240-7329","authenticated-orcid":false,"given":"Yasmine","family":"Gaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-0130","authenticated-orcid":false,"given":"Shereen","family":"Abdel Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherief","family":"Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-1544","authenticated-orcid":false,"given":"Tarek","family":"Elnagdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-9106","authenticated-orcid":false,"given":"Wael A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raafat Zaher","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Gad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedy A.","family":"Badary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Meguid","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/covid1010004","article-title":"The role of serology testing to strengthen vaccination initiatives and policies for COVID-19 in Europe","volume":"1","author":"Bonanni","year":"2021","journal-title":"COVID"},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0002","first-page":"1","article-title":"Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"17","key":"10.1016\/j.virusres.2022.198852_bib0003","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.virusres.2022.198852_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102489","article-title":"Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients","volume":"24","author":"Dwyer","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.virusres.2022.198852_bib0005","unstructured":"FDA, 2020. Recommendations for investigational COVID-19 convalescent plasma. FDA; 2020 https:\/\/www.fda.gov\/vaccinesblood-biologics\/investigational-new-drug-ind-or-device-exemption-ide-process-cber\/recommendations-investigationalcovid-19-convalescent-plasma. Accessed June 2020."},{"issue":"5","key":"10.1016\/j.virusres.2022.198852_bib0006","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/trf.16283","article-title":"Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trial","volume":"61","author":"Freedenberg","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17317-y","article-title":"An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment","volume":"11","author":"GeurtsvanKessel","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.virusres.2022.198852_bib0008","article-title":"Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19","volume":"2","author":"Goh","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.virusres.2022.198852_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jalm\/jfaa195","article-title":"Correlation of SARS-CoV-2 neutralizing antibodies to an automated chemiluminescent serological immunoassay","volume":"6","author":"Grenache","year":"2021","journal-title":"J. Appl. Lab. Med."},{"issue":"15","key":"10.1016\/j.virusres.2022.198852_bib0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"10223","key":"10.1016\/j.virusres.2022.198852_bib0011","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet North Am. Ed."},{"issue":"7","key":"10.1016\/j.virusres.2022.198852_bib0012","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.arth.2020.04.055","article-title":"Understanding antibody testing for COVID-19","volume":"35","author":"Jacofsky","year":"2020","journal-title":"J. Arthroplast."},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81629-2","article-title":"SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness","volume":"11","author":"Jeewandara","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.virusres.2022.198852_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241471","article-title":"Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2","volume":"15","author":"Kandeil","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/jiaa673","article-title":"Neutralizing antibody responses in COVID-19 convalescent sera","volume":"223","author":"Lee","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2022.198852_bib0016","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2022.198852_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7883\/yoken.JJID.2020.799","article-title":"Early anti-SARS-CoV-2 immunoglobulin G response may be associated with disease severity in patients with COVID-19","volume":"74","author":"Maeda","year":"2021","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198852_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/1744666X.2021.1908886","article-title":"A comparative review of immunoassays for COVID-19 detection","author":"Mohit","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1-2","key":"10.1016\/j.virusres.2022.198852_bib0019","article-title":"Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody","volume":"1","author":"Moscato","year":"2021","journal-title":"J. Clin. Virol. Plus"},{"key":"10.1016\/j.virusres.2022.198852_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2021.06.001","article-title":"Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: a prospective cohort study","author":"Musa","year":"2021","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82428-5","article-title":"Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan","volume":"11","author":"Nakano","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2022.198852_bib0022","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2021-0313","article-title":"Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers","author":"Padoan","year":"2021","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"10237","key":"10.1016\/j.virusres.2022.198852_bib0023","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)31034-5","article-title":"COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges","volume":"395","author":"Phelan","year":"2020","journal-title":"Lancet North Am. Ed."},{"issue":"4","key":"10.1016\/j.virusres.2022.198852_bib0026","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/diagnostics11040593","article-title":"Five commercial immunoassays for SARS-CoV-2 antibody determination and their comparison and correlation with the virus neutralization test","volume":"11","author":"\u0160im\u00e1nek","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.virusres.2022.198852_bib0024","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1172\/JCI141206","article-title":"Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization","volume":"130","author":"Salazar","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.virusres.2022.198852_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/bioengineering8050054","article-title":"COVID-19 diagnostic strategies part II: protein-based technologies","volume":"8","author":"Shaffaf","year":"2021","journal-title":"Bioengineering"},{"issue":"13","key":"10.1016\/j.virusres.2022.198852_bib0027","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2020.16656","article-title":"COVID-19 and the Path to Immunity","volume":"324","author":"Stephens","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.virusres.2022.198852_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2020.08.001","article-title":"The interpretation of SARS-CoV-2 diagnostic tests","author":"Stites","year":"2020","journal-title":"Med"},{"issue":"2","key":"10.1016\/j.virusres.2022.198852_bib0029","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/clinchem\/hvaa262","article-title":"Commercial serology assays predict neutralization activity against SARS-CoV-2","volume":"67","author":"Suhandynata","year":"2021","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.virusres.2022.198852_bib0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"7809","key":"10.1016\/j.virusres.2022.198852_bib0033","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2022.198852_bib0031","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1080\/22221751.2020.1826362","article-title":"Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"7","key":"10.1016\/j.virusres.2022.198852_bib0032","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1473-3099(20)30322-4","article-title":"The important role of serology for COVID-19 control","volume":"20","author":"Winter","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2022.198852_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115140","article-title":"Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays","volume":"98","author":"Wolff","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virusres.2022.198852_bib0035","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 133. 1 June 2020."},{"key":"10.1016\/j.virusres.2022.198852_bib0036","unstructured":"World Health Organization. WHO director-general's opening remarks at the media briefing on COVID-19\u201311 March 2020. 2020; Available from: https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201411-march-2020."},{"issue":"6483","key":"10.1016\/j.virusres.2022.198852_bib0037","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2022.198852_bib0038","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, 2020","author":"Wu","year":"2020","journal-title":"J"},{"issue":"16","key":"10.1016\/j.virusres.2022.198852_bib0039","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2022.198852_bib0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222001800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170222001800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:16:43Z","timestamp":1759155403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170222001800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":40,"alternative-id":["S0168170222001800"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198852","relation":{},"ISSN":["0168-1702"],"issn-type":[{"type":"print","value":"0168-1702"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2022.198852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198852"}}